Education
About Us
Working with TipRanks
Follow Us
Zimmer Biomet Holdings (ZBH)
:ZBH
Earnings Data
Report Date
Aug 05, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
1.98Last Year’s EPS
2.01Same Quarter Last Year
Based on 21 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 05, 2025
|% Change Since: -6.87%
|Next Earnings Date:Aug 05, 2025
Earnings Call Sentiment|Neutral
Zimmer Biomet reported solid performance in key product segments and successfully integrated the Paragon 28 acquisition. However, the company faces challenges from tariff impacts and lower than expected U.S. Knees growth, leading to a downward revision in EPS and free cash flow guidance.Company Guidance
During Zimmer Biomet's First Quarter 2025 Earnings Conference Call, management provided guidance on several key metrics. The company reported a constant currency sales growth of 2.3% for the quarter, with standout results in U.S. Hips, which grew nearly 4%, and mid-single-digit growth in their S.E.T. segment. Despite a challenging quarter with one less selling day, Zimmer Biomet maintained its full-year organic constant currency revenue growth expectations of 3% to 5%, excluding contributions from its recent Paragon 28 acquisition, which is anticipated to contribute 270 basis points to sales growth. Adjusted EPS guidance was updated to $7.90 to $8.10, down from the previous $8.15 to $8.35, due to tariff impacts and modest dilution from the Paragon 28 acquisition. The company also highlighted its focus on innovation, diversification, and operational excellence as strategic priorities for 2025.Solid First Quarter Performance
Zimmer Biomet reported a 2.3% sales growth on a constant currency basis, with notable growth in U.S. Hips up nearly 4% and mid-single digit growth in S.E.T.
Positive Pricing Trend
Consolidated pricing was positive for the fifth consecutive quarter, marking a 10 basis points increase, contributing to the overall revenue.
Successful Integration of Paragon 28
The Paragon 28 acquisition was successfully integrated with minimal disruption, retaining key leadership and the U.S. sales channel, expected to contribute 270 basis points to 2025 sales growth.
Strong Free Cash Flow
Zimmer Biomet generated $279 million in free cash flow, demonstrating robust cash generation and working capital improvements.
Continued Innovation and Product Launches
The company is focusing on new product introductions, including the Persona OsseoTi Cementless Knee and Oxford Partial Cementless Knee, with significant training efforts underway.
---
ZBH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ZBH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 05, 2025 | $102.38 | $90.48 | -11.62% |
Feb 06, 2025 | $108.02 | $102.47 | -5.14% |
Oct 30, 2024 | $103.42 | $109.33 | +5.71% |
Aug 07, 2024 | $108.85 | $105.11 | -3.44% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Zimmer Biomet Holdings (ZBH) report earnings?
Zimmer Biomet Holdings (ZBH) is schdueled to report earning on Aug 05, 2025, TBA Not Confirmed.
What is Zimmer Biomet Holdings (ZBH) earnings time?
Zimmer Biomet Holdings (ZBH) earnings time is at Aug 05, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ZBH EPS forecast?
ZBH EPS forecast for the fiscal quarter 2025 (Q2) is 1.98.
---